Moreover, in pancreatic cancer xenografts, ATO in combination with gemcitabine reduced CD24−/CD44+ and ALDH1A1+ CSC populations and inhibited tumor growth [542]. This evidence concerns the gene CD24 and familial pancreatic carcinoma.